Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Effects of Chemicals: Overview01:27

Effects of Chemicals: Overview

Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pre-liver transplant assessment of patients with acute-on-chronic liver failure: An international survey.

JHEP reports : innovation in hepatology·2026
Same author

Second-Line Practices in the Era of Immunotherapy in HCC: The CHIEF Cohort.

JHEP reports : innovation in hepatology·2026
Same author

Impact of an educational video on the quality of bowel preparation prior to colonoscopy: a randomized controlled study.

Clinics and research in hepatology and gastroenterology·2026
Same author

HCV Screening Before Endoscopy in Hepatogastroenterology Outpatient Clinic: The Depist C Endo Study.

Journal of viral hepatitis·2025
Same author

Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled trial.

Journal of hepatology·2025
Same author

Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis.

Journal of hepatology·2025

Related Experiment Video

Updated: May 25, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Management of side-effects.

Isabelle Rosa1

  • 1Department of Hepato-gastroenterology, Centre Hospitalier Intercommunal de Créteil, France. isabelle.rosa@chicreteil.fr

Clinics and Research in Hepatology and Gastroenterology
|January 18, 2012
PubMed
Summary

New triple therapies for hepatitis C (HCV) combining pegylated interferon, ribavirin, and direct-acting antivirals (DAAs) improve viral response but increase adverse events. Careful patient management is crucial to mitigate these risks.

Area of Science:

  • Hepatology
  • Pharmacology
  • Clinical Medicine

Background:

  • Current chronic hepatitis C treatment involves triple therapy with pegylated interferon, ribavirin, and direct-acting antivirals (DAAs) like telaprevir or boceprevir.
  • This combination improves viral response rates but is associated with increased adverse events, potentially leading to treatment discontinuation.

Purpose of the Study:

  • To evaluate the efficacy and safety profile of triple antiviral therapy for chronic hepatitis C.
  • To highlight the increased incidence and management of adverse events associated with direct-acting antiviral combinations.

Main Methods:

  • Review of clinical data on triple combination therapy for chronic hepatitis C.
  • Analysis of adverse events, including dermatological side-effects and anemia, in patients receiving telaprevir or boceprevir regimens.

Related Experiment Videos

Last Updated: May 25, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Main Results:

  • Triple therapy demonstrates higher viral response rates.
  • Increased risks of dermatological side-effects (rash) and anemia were observed, necessitating specific management strategies.
  • Severe cutaneous adverse reactions (SCARs) and drug reactions with eosinophilia and systemic symptoms (DRESS) require careful differentiation.

Conclusions:

  • While effective, triple antiviral therapy for chronic hepatitis C necessitates enhanced clinical and biological monitoring.
  • Management of adverse events, such as skin reactions and anemia, is critical for treatment continuation and patient outcomes.
  • The findings underscore the need for tailored patient management strategies in the era of direct-acting antiviral combination therapies.